From peptides to non-peptide peptidomimetics: Design and synthesis of new piperidine inhibitors of aspartic peptidases

被引:58
作者
Bursavich, MG
West, CW
Rich, DH
机构
[1] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA
关键词
D O I
10.1021/ol016092u
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
[GRAPHICS] The 3-alkoxy-4-arylpiperidine inhibitors of aspartic peptidases are shown to be a new type of non-peptide peptidomimetic inhibitor. These piperidines can be designed from peptide derived inhibitors by use of a structure generating program but only after the enzyme active site conformation has been modified in a mechanistically related fashion. New enantioselective syntheses of 3-alkoxy-4-arylpiperidine analogues are described.
引用
收藏
页码:2317 / 2320
页数:4
相关论文
共 35 条
[1]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[2]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO
[3]  
2-D
[4]   Design and synthesis of unsymmetrical peptidyl urea inhibitors of aspartic peptidases [J].
Dales, NA ;
Bohacek, RS ;
Satyshur, KA ;
Rich, DH .
ORGANIC LETTERS, 2001, 3 (15) :2313-2316
[5]   Conformational selection of inhibitors and substrates by proteolytic enzymes: Implications for drug design and polypeptide processing [J].
Fairlie, DP ;
Tyndall, JDA ;
Reid, RC ;
Wong, AK ;
Abbenante, G ;
Scanlon, MJ ;
March, DR ;
Bergman, DA ;
Chai, CLL ;
Burkett, BA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (07) :1271-1281
[6]  
Farmer P. S., 1980, DRUG DESIGN, V10, P119
[7]   Purification and crystallization of rhizopuspepsin: The use of nickel chelation chromatography to select for catalytically active species [J].
Flentke, GR ;
Glinski, J ;
Satyshur, K ;
Rich, DH .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (02) :213-220
[8]   Nonpeptidic ligands for peptide and protein receptors [J].
Freidinger, RM .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :395-406
[9]   Piperidine-renin inhibitors compounds with improved physicochemical properties [J].
Güller, R ;
Binggeli, A ;
Breu, V ;
Bur, D ;
Fischli, W ;
Hirth, G ;
Jenny, C ;
Kansy, M ;
Montavon, F ;
Müller, M ;
Oefner, C ;
Stadler, H ;
Vieira, E ;
Wilhelm, M ;
Wostl, W ;
Märki, HP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (10) :1403-1408
[10]  
Hagen S, 2000, ADV MED CH, V5, P159, DOI 10.1016/S1067-5698(00)80006-1